Mounting
 evidence shows ‘cannabinoids’ in marijuana slow cancer growth, inhibit 
formation of new blood cells that feed a tumor, and help manage pain, 
fatigue, nausea, and other side effects. Peer-reviewed studies 
in several countries ... show that THC and other marijuana-derived 
compounds, known as “cannabinoids,” are effective not only for 
cancer-symptom management (nausea, pain, loss of appetite, fatigue), 
they also confer a direct antitumoral effect. A team of Spanish 
scientists led by Manuel Guzman conducted the first clinical trial 
assessing the antitumoral action of THC on human beings. THC treatment 
was associated with significantly reduced tumor cell proliferation in 
every test subject. Harvard University scientists reported that THC 
slows tumor growth in common lung cancer and “significantly reduces the 
ability of the cancer to spread.” What’s more ... THC selectively 
targets and destroys tumor cells while leaving healthy cells unscathed. 
Conventional chemotherapy drugs, by contrast, are highly toxic; they 
indiscriminately damage the brain and body. There is mounting evidence 
... that cannabinoids “represent a new class of anticancer drugs that 
retard cancer growth, inhibit angiogenesis [the formation of new blood 
cells that feed a tumor] and the metastatic spreading of cancer cells.” Within
 the medical science community, the discovery that cannabinoids have 
anti-tumoral properties is increasingly recognized as a seminal 
advancement in cancer therapeutics.
Note:
 Yet treatment with cannabinoids continues to be largely illegal in the 
US. For an informative 15-minute documentary on the health benefits of 
juicing raw cannabis, For deeply revealing reports from reliable major media sources on promising cancer-cure research, 
 
No comments:
Post a Comment